Wellbiotec Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was KRW 19,613.11 million compared to KRW 67,430.8 million a year ago. Basic loss per share from continuing operations was KRW 383 compared to KRW 1,165 a year ago.

Diluted loss per share from continuing operations was KRW 383. Basic loss per share was KRW 354 compared to KRW 1,543 a year ago. Diluted loss per share was KRW 354 compared to KRW 1,543 a year ago.